{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:4ec29ca5-779d-4871-91c1-8e6b27742832","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T21:09:59.466988+00:00","published_at":"2026-10-17T04:45:33.016234+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:y6f001y2utgc","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:christobel-selecky","alpha:company:4ec29ca5-779d-4871-91c1-8e6b27742832"],"caused_claim_ids":["alpha:claim:company:4ec29ca5-779d-4871-91c1-8e6b27742832:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:33be6cc3a7053d6357847bd5e8cdd3d8efd8b462c6dbedfbe3a5060a04ed50d7"],"summary":"Christobel Selecky seat on ImmunityBio, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:eo8ozd1vbvwhx","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:linda-maxwell","alpha:company:4ec29ca5-779d-4871-91c1-8e6b27742832"],"caused_claim_ids":["alpha:claim:company:4ec29ca5-779d-4871-91c1-8e6b27742832:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:33be6cc3a7053d6357847bd5e8cdd3d8efd8b462c6dbedfbe3a5060a04ed50d7"],"summary":"Linda Maxwell seat on ImmunityBio, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:tkcji9gggrsb","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:richard-adcock","alpha:company:4ec29ca5-779d-4871-91c1-8e6b27742832"],"caused_claim_ids":["alpha:claim:company:4ec29ca5-779d-4871-91c1-8e6b27742832:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:33be6cc3a7053d6357847bd5e8cdd3d8efd8b462c6dbedfbe3a5060a04ed50d7"],"summary":"Richard Adcock seat on ImmunityBio, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:yorhiar435p2","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:wesley-clark","alpha:company:4ec29ca5-779d-4871-91c1-8e6b27742832"],"caused_claim_ids":["alpha:claim:company:4ec29ca5-779d-4871-91c1-8e6b27742832:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:33be6cc3a7053d6357847bd5e8cdd3d8efd8b462c6dbedfbe3a5060a04ed50d7"],"summary":"Wesley Clark seat on ImmunityBio, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ynzctk1xdoxt0","event_type":"COMMITTEE_CREATED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:committee:immunitybio-inc:audit-compensation","alpha:company:4ec29ca5-779d-4871-91c1-8e6b27742832"],"caused_claim_ids":["alpha:claim:company:4ec29ca5-779d-4871-91c1-8e6b27742832:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:33be6cc3a7053d6357847bd5e8cdd3d8efd8b462c6dbedfbe3a5060a04ed50d7"],"summary":"Audit; Compensation committee of ImmunityBio, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:selnvo6t5yrw","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:christobel-selecky","alpha:committee:immunitybio-inc:audit-compensation"],"caused_claim_ids":["alpha:claim:company:4ec29ca5-779d-4871-91c1-8e6b27742832:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:33be6cc3a7053d6357847bd5e8cdd3d8efd8b462c6dbedfbe3a5060a04ed50d7"],"summary":"Christobel Selecky member of Audit; Compensation, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:hhhmbl9dm5h","event_type":"COMMITTEE_CREATED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:committee:immunitybio-inc:audit-compensation-chair","alpha:company:4ec29ca5-779d-4871-91c1-8e6b27742832"],"caused_claim_ids":["alpha:claim:company:4ec29ca5-779d-4871-91c1-8e6b27742832:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:33be6cc3a7053d6357847bd5e8cdd3d8efd8b462c6dbedfbe3a5060a04ed50d7"],"summary":"Audit; Compensation · Chair committee of ImmunityBio, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1w3urcr1a6gxl1","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:linda-maxwell","alpha:committee:immunitybio-inc:audit-compensation-chair"],"caused_claim_ids":["alpha:claim:company:4ec29ca5-779d-4871-91c1-8e6b27742832:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:33be6cc3a7053d6357847bd5e8cdd3d8efd8b462c6dbedfbe3a5060a04ed50d7"],"summary":"Linda Maxwell member of Audit; Compensation · Chair, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1bbuj9sa5td48","event_type":"DIRECTOR_APPOINTED","effective_at":"2019-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:cheryl-l-cohen","alpha:company:4ec29ca5-779d-4871-91c1-8e6b27742832"],"caused_claim_ids":["alpha:claim:company:4ec29ca5-779d-4871-91c1-8e6b27742832:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:33be6cc3a7053d6357847bd5e8cdd3d8efd8b462c6dbedfbe3a5060a04ed50d7"],"summary":"Cheryl L. Cohen seat on ImmunityBio, Inc., effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:l2pd4pue2g0","event_type":"COMMITTEE_CREATED","effective_at":"2019-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:committee:immunitybio-inc:audit-nominating-and-governance","alpha:company:4ec29ca5-779d-4871-91c1-8e6b27742832"],"caused_claim_ids":["alpha:claim:company:4ec29ca5-779d-4871-91c1-8e6b27742832:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:33be6cc3a7053d6357847bd5e8cdd3d8efd8b462c6dbedfbe3a5060a04ed50d7"],"summary":"Audit; Nominating and Governance committee of ImmunityBio, Inc., effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:2m9k9xkxkeu3","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2019-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:cheryl-l-cohen","alpha:committee:immunitybio-inc:audit-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:4ec29ca5-779d-4871-91c1-8e6b27742832:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:33be6cc3a7053d6357847bd5e8cdd3d8efd8b462c6dbedfbe3a5060a04ed50d7"],"summary":"Cheryl L. Cohen member of Audit; Nominating and Governance, effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:c2sgdm96afz6","event_type":"DIRECTOR_APPOINTED","effective_at":"2015-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:michael-d-blaszyk","alpha:company:4ec29ca5-779d-4871-91c1-8e6b27742832"],"caused_claim_ids":["alpha:claim:company:4ec29ca5-779d-4871-91c1-8e6b27742832:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:33be6cc3a7053d6357847bd5e8cdd3d8efd8b462c6dbedfbe3a5060a04ed50d7"],"summary":"Michael D. Blaszyk seat on ImmunityBio, Inc., effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1v4ywyq1401nqi","event_type":"COMMITTEE_CREATED","effective_at":"2015-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:committee:immunitybio-inc:audit-chair-compensation","alpha:company:4ec29ca5-779d-4871-91c1-8e6b27742832"],"caused_claim_ids":["alpha:claim:company:4ec29ca5-779d-4871-91c1-8e6b27742832:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:33be6cc3a7053d6357847bd5e8cdd3d8efd8b462c6dbedfbe3a5060a04ed50d7"],"summary":"Audit · Chair; Compensation committee of ImmunityBio, Inc., effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:8pcgme70o8wm","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2015-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:michael-d-blaszyk","alpha:committee:immunitybio-inc:audit-chair-compensation"],"caused_claim_ids":["alpha:claim:company:4ec29ca5-779d-4871-91c1-8e6b27742832:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:33be6cc3a7053d6357847bd5e8cdd3d8efd8b462c6dbedfbe3a5060a04ed50d7"],"summary":"Michael D. Blaszyk member of Audit · Chair; Compensation, effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:19md9lm1tm2s0a","event_type":"DIRECTOR_APPOINTED","effective_at":"2014-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:patrick-soon-shiong","alpha:company:4ec29ca5-779d-4871-91c1-8e6b27742832"],"caused_claim_ids":["alpha:claim:company:4ec29ca5-779d-4871-91c1-8e6b27742832:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:33be6cc3a7053d6357847bd5e8cdd3d8efd8b462c6dbedfbe3a5060a04ed50d7"],"summary":"Patrick Soon-Shiong seat on ImmunityBio, Inc., effective 2014-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:b0yqgu164v4mi","event_type":"COMMITTEE_CREATED","effective_at":"2014-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:committee:immunitybio-inc:nominating-and-governance-chair","alpha:company:4ec29ca5-779d-4871-91c1-8e6b27742832"],"caused_claim_ids":["alpha:claim:company:4ec29ca5-779d-4871-91c1-8e6b27742832:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:33be6cc3a7053d6357847bd5e8cdd3d8efd8b462c6dbedfbe3a5060a04ed50d7"],"summary":"Nominating and Governance · Chair committee of ImmunityBio, Inc., effective 2014-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:wdctrh17n7ord","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2014-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:patrick-soon-shiong","alpha:committee:immunitybio-inc:nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:4ec29ca5-779d-4871-91c1-8e6b27742832:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:33be6cc3a7053d6357847bd5e8cdd3d8efd8b462c6dbedfbe3a5060a04ed50d7"],"summary":"Patrick Soon-Shiong member of Nominating and Governance · Chair, effective 2014-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1tfqx1m1z102e","event_type":"DIRECTOR_APPOINTED","effective_at":"2007-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:barry-j-simon","alpha:company:4ec29ca5-779d-4871-91c1-8e6b27742832"],"caused_claim_ids":["alpha:claim:company:4ec29ca5-779d-4871-91c1-8e6b27742832:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:33be6cc3a7053d6357847bd5e8cdd3d8efd8b462c6dbedfbe3a5060a04ed50d7"],"summary":"Barry J. Simon seat on ImmunityBio, Inc., effective 2007-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:4ec29ca5-779d-4871-91c1-8e6b27742832:leadership_role:6","subject_id":"alpha:company:4ec29ca5-779d-4871-91c1-8e6b27742832","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:barry-j-simon","object_label":"Barry J. Simon","object_source_name_forms":[],"value":"Barry J. Simon: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:barry-j-simon","name":"Barry J. Simon"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2007-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2007-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:33be6cc3a7053d6357847bd5e8cdd3d8efd8b462c6dbedfbe3a5060a04ed50d7","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ImmunityBio Inc DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000054/ibrx-20250429.htm","source_date":"2025-04-30","retrieved_at":"2026-05-11T00:20:33.708+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2007-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4ec29ca5-779d-4871-91c1-8e6b27742832:leadership_role:7","subject_id":"alpha:company:4ec29ca5-779d-4871-91c1-8e6b27742832","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:cheryl-l-cohen","object_label":"Cheryl L. Cohen","object_source_name_forms":[],"value":"Cheryl L. Cohen: Director, Audit; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:cheryl-l-cohen","name":"Cheryl L. Cohen"},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:33be6cc3a7053d6357847bd5e8cdd3d8efd8b462c6dbedfbe3a5060a04ed50d7","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ImmunityBio Inc DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000054/ibrx-20250429.htm","source_date":"2025-04-30","retrieved_at":"2026-05-11T00:20:33.708+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4ec29ca5-779d-4871-91c1-8e6b27742832:leadership_role:8","subject_id":"alpha:company:4ec29ca5-779d-4871-91c1-8e6b27742832","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:christobel-selecky","object_label":"Christobel Selecky","object_source_name_forms":[],"value":"Christobel Selecky: Director, Audit; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:christobel-selecky","name":"Christobel Selecky"},"title":"Director","role_category":"director","committee":"Audit; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:33be6cc3a7053d6357847bd5e8cdd3d8efd8b462c6dbedfbe3a5060a04ed50d7","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ImmunityBio Inc DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000054/ibrx-20250429.htm","source_date":"2025-04-30","retrieved_at":"2026-05-11T00:20:33.708+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4ec29ca5-779d-4871-91c1-8e6b27742832:leadership_role:9","subject_id":"alpha:company:4ec29ca5-779d-4871-91c1-8e6b27742832","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:linda-maxwell","object_label":"Linda Maxwell","object_source_name_forms":[],"value":"Linda Maxwell: Director, Audit; Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:linda-maxwell","name":"Linda Maxwell"},"title":"Director","role_category":"director","committee":"Audit; Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:33be6cc3a7053d6357847bd5e8cdd3d8efd8b462c6dbedfbe3a5060a04ed50d7","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ImmunityBio Inc DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000054/ibrx-20250429.htm","source_date":"2025-04-30","retrieved_at":"2026-05-11T00:20:33.708+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4ec29ca5-779d-4871-91c1-8e6b27742832:leadership_role:10","subject_id":"alpha:company:4ec29ca5-779d-4871-91c1-8e6b27742832","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:michael-d-blaszyk","object_label":"Michael D. Blaszyk","object_source_name_forms":[],"value":"Michael D. Blaszyk: Director, Audit · Chair; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:michael-d-blaszyk","name":"Michael D. Blaszyk"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:33be6cc3a7053d6357847bd5e8cdd3d8efd8b462c6dbedfbe3a5060a04ed50d7","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ImmunityBio Inc DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000054/ibrx-20250429.htm","source_date":"2025-04-30","retrieved_at":"2026-05-11T00:20:33.708+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4ec29ca5-779d-4871-91c1-8e6b27742832:leadership_role:11","subject_id":"alpha:company:4ec29ca5-779d-4871-91c1-8e6b27742832","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:patrick-soon-shiong","object_label":"Patrick Soon-Shiong","object_source_name_forms":[],"value":"Patrick Soon-Shiong: Director, Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:patrick-soon-shiong","name":"Patrick Soon-Shiong"},"title":"Director","role_category":"director","committee":"Nominating and Governance · Chair","is_board_chair":false,"is_independent":false,"start_date":"2014-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2014-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:33be6cc3a7053d6357847bd5e8cdd3d8efd8b462c6dbedfbe3a5060a04ed50d7","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ImmunityBio Inc DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000054/ibrx-20250429.htm","source_date":"2025-04-30","retrieved_at":"2026-05-11T00:20:33.708+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2014-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4ec29ca5-779d-4871-91c1-8e6b27742832:leadership_role:12","subject_id":"alpha:company:4ec29ca5-779d-4871-91c1-8e6b27742832","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:richard-adcock","object_label":"Richard Adcock","object_source_name_forms":[],"value":"Richard Adcock: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:richard-adcock","name":"Richard Adcock"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:33be6cc3a7053d6357847bd5e8cdd3d8efd8b462c6dbedfbe3a5060a04ed50d7","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ImmunityBio Inc DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000054/ibrx-20250429.htm","source_date":"2025-04-30","retrieved_at":"2026-05-11T00:20:33.708+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4ec29ca5-779d-4871-91c1-8e6b27742832:leadership_role:13","subject_id":"alpha:company:4ec29ca5-779d-4871-91c1-8e6b27742832","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:wesley-clark","object_label":"Wesley Clark","object_source_name_forms":[],"value":"Wesley Clark: Director, Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:wesley-clark","name":"Wesley Clark"},"title":"Director","role_category":"director","committee":"Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:33be6cc3a7053d6357847bd5e8cdd3d8efd8b462c6dbedfbe3a5060a04ed50d7","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ImmunityBio Inc DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000054/ibrx-20250429.htm","source_date":"2025-04-30","retrieved_at":"2026-05-11T00:20:33.708+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:33be6cc3a7053d6357847bd5e8cdd3d8efd8b462c6dbedfbe3a5060a04ed50d7","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ImmunityBio Inc DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000054/ibrx-20250429.htm","source_date":"2025-04-30","retrieved_at":"2026-05-11T00:20:33.708+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.815,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.805,"cross_source_agreement":0.75,"temporal_completeness":0.381},"diagnostics":{"published_claims":29,"factual_claims":29,"claims_with_linked_evidence":29,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":21,"temporal_claims_with_valid_from":8,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-17T04:45:33.016234+00:00","observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":"2026-10-17T04:45:33.016234+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":29,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/immunitybio-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/immunitybio-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}